Zennova Pharmaceutical (Chengdu) Co., Ltd. (referred to as "Zennova") has successfully achieved the esteemed status of "The National High-Tech Enterprises" in 2022.
The2021TianfuIntellectualPropertySummitwasheldinChengduonSeptember23,2021.LuoQiang,ViceGovernorofSichuanProvince,GanShaoning,DeputyDirectoroftheChinaNationalIntellectualPropertyAdministration,andLiuHu...
Zennova Pharmaceutical has successfully completed its Series A fund raising of tens of millions of RMB from Dyee Capital, the lead investor, and Shining Capital,the co-investor, on August 23, 2021.